Tonix Pharmaceuticals Holding Corp (TNXP)
0.1767
-0.15
(-45.95%)
USD |
NASDAQ |
Mar 28, 16:00
0.202
+0.03
(+14.32%)
After-Hours: 20:00
Tonix Pharmaceuticals Gross Profit Margin (Quarterly): 40.49% for Sept. 30, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 40.49% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
40.49%
Minimum
Sep 2023
40.49%
Maximum
Sep 2023
40.49%
Average
40.49%
Median
Sep 2023
Gross Profit Margin (Quarterly) Benchmarks
ACADIA Pharmaceuticals Inc | 92.26% |
PetVivo Holdings Inc | 69.28% |
Acurx Pharmaceuticals Inc | -- |
Eli Lilly and Co | 80.88% |
Kezar Life Sciences Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
Profit Margin (Quarterly) | -701.3% |
Operating Margin (Quarterly) | -705.6% |